http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05010457-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d1e743e26840f0b13535747a35c2ca5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2005-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9b1ff86fe3f4f85dd918c871576ddb3 |
publicationDate | 2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | MX-PA05010457-A |
titleOfInvention | PREPARATION FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES, CONTAINING TACROLIMUS. |
abstract | The present invention is related to the pharmaceutical industry in general and to the pharmaceutical industry related to products of particular dermal application. Specifically it refers to a topical preparation for the treatment of inflammatory diseases of the skin in the form of ointment. With respect to the products of the state of the art, our product has the advantage of having specific therapeutic action in the treatment of inflammatory skin diseases with a broad safety profile for the patient, with a percutaneous absorption and penetration suitable for its purpose. , being an additional advantage its use in monotherapy and a great stability. The product is characterized by comprising in its composition Propylene Glycol, Ultra White Petrolatum, antioxidant, Mineral Oil, Emulsifiers, Waxes. |
priorityDate | 2005-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.